RITA 3 Trial: Interventional vs. Conservative Strategy in UA/NSTEMI

RITA 3 Trial Summary Background: Methods: Findings: Interpretation: Key Takeaways: Source

POPular AGE Trial Summary: Antiplatelet agent in NSTEMI

2020 POPULAR AGE TRIAL Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome multicenter, randomized controlled trial Objective: To evaluate the effectiveness of clopidogrel compared with ticagrelor or prasugrel among patients ≥70 … Read More